The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these ...

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish ...

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...

Early physical therapy initiation at cancer diagnosis can prevent or minimize treatment-related side effects, enhancing ...

We were barely through with the first week of the New Year when the weather began to get ugly. Listening to weather reports, ...

Melissa Ursini discussed her experience with a colorectal cancer diagnosis at age 37, highlighting her insights during ...

March is Kidney Cancer Awareness Month, highlighting the disease, early detection and and patient advocacy, with voices like ...